TIDMAGY

RNS Number : 9140Z

Allergy Therapeutics PLC

16 December 2014

16 December 2014

Allergy Therapeutics plc

("Allergy Therapeutics" or the "Company")

Change of Adviser

Allergy Therapeutics plc, the fully integrated specialty pharmaceutical company specialising in allergy vaccines, announces the appointment, with immediate effect, of Panmure Gordon (UK) Limited as its Nominated Adviser and Broker.

-Ends-

For further information

 
 Allergy Therapeutics                      +44 (0) 1903 845 820 
 Manuel Llobet, Chief Executive Officer 
 Ian Postlethwaite Finance Director 
 
 Panmure Gordon                            +44 (0) 20 7886 2500 
 Freddy Crossley / Duncan Monteith, 
  Corporate Finance 
 Tom Salvesen, Corporate Broking 
 
 FTI Consulting                            +44 (0) 20 3727 1000 
 Simon Conway 
 Victoria Foster Mitchell

About Allergy Therapeutics

Allergy Therapeutics is a specialty pharmaceutical company focused on allergy vaccination. Ithas a growing business achieving revenue in thelast financial yearof GBP42 million mainly in Europe through its own sales and marketing infrastructure and further afield through distributors. The Company is expanding its infrastructure into theEmerging markets.

This information is provided by RNS

The company news service from the London Stock Exchange

END

APPKMMMZZVZGDZM

Allergy Therapeutics (LSE:AGY)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Allergy Therapeutics Charts.
Allergy Therapeutics (LSE:AGY)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Allergy Therapeutics Charts.